Bavarian Nordic A/S ( BVNKF) - Stock Earnings
BVNKF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
BVNKF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -46.9 million USD | 221.6 million USD |
| 2026Q1 | 2.6 million USD | 162.6 million USD |
| 2026Q2 | 111.3 million USD | 309.0 million USD |
| 2026Q4 Est. | — | — |
BVNKF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 218.4 million USD | 1.0 billion USD |
| 2024 | 137.9 million USD | 798.1 million USD |
| 2025 | 215.7 million USD | 967.7 million USD |
| 2026 Est. | — | — |
BVNKF
Price: $36.06
52 week price:
Earnings Per Share: 3.03 USD
P/E Ratio: 10.75
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.6 billion